Quantcast

Latest Health Medical Pharma Stories

2014-10-20 08:32:07

LONDON, October 20, 2014 /PRNewswire/ -- Norgine B.V. today announced that the Phase II study of its novel, low volume bowel preparation, NER1006, presented at the 79th Annual Scientific Meeting of the American College of Gastroenterology (ACG), Philadelphia, PA, has met its primary efficacy end point of stool weight and co-primary endpoint of cleansing success. The study demonstrated high quality bowel cleansing efficacy with NER1006 vs. MOVIPREP(R) in screening colonoscopy...

2014-10-20 08:32:05

First Plasma-Medicine System Designed for Operating Room Use for Incision Closure YOKNEAM, Israel, October 20, 2014 /PRNewswire/ -- IonMed [http://www.ion-med.com ] announced today that it has received CE Mark clearance for its Bioweld1(TM) cold plasma system for surgical incision closure. Bioweld1 is the first system in the rapidly emerging field of plasma medicine designed for use in operating room settings as an alternative to surgical staples, sutures and sealants....

2014-10-20 08:31:57

SAN DIEGO, Oct. 20, 2014 /PRNewswire/ -- AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies, today announced the appointment of Marco Londei, M.D. as Chief Development Officer. Dr. Londei will lead the preclinical and clinical development of AnaptysBio's proprietary antibody pipeline. http://photos.prnewswire.com/prnvar/20111205/SF16052LOGO "We are pleased to welcome Dr. Londei to AnaptysBio's executive leadership team," said Hamza Suria,...

2014-10-20 08:31:54

GAITHERSBURG, Md., Oct. 20, 2014 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) today announced the retirement of Zola P. Horovitz, Ph.D., from its board of directors effective on October 24, 2014. Dr. Horovitz joined the GenVec board in August 2003, and served as its chairman from June 2006 to November 2013. During his tenure, he also served on the Nominating and Corporate Governance and Audit Committees of the board. "We deeply thank Zola for more than a decade of dedicated...

2014-10-20 08:31:51

BRIDGEWATER, N.J., Oct. 20, 2014 /PRNewswire/ -- Valeritas, Inc., a leader in simple, disposable basal-bolus insulin delivery technology designed for patients with Type 2 diabetes, announced today that it has received a 2014 Cardinal Health Supply Chain Excellence Award. The award was presented October 16(th) at Cardinal's annual Business Partners Conference in Columbus, Ohio. The Cardinal Health Supply Chain Excellence Award recipients are judged across a variety of metrics...

2014-10-20 08:31:48

Filing completed just three months after receipt of third FDA approval SUNNYVALE, Calif., Oct. 20, 2014 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC) today announced that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) based on data from a Phase 2 study evaluating the use of IMBRUVICA(®) (ibrutinib) in patients with Waldenstrom's macroglobulinemia (WM), which was led by Dr. Steven Treon from the Dana-Farber Cancer...

2014-10-20 08:31:47

ALBANY, N.Y., Oct. 20, 2014 /PRNewswire/ -- Pharmaceutic Labs announces the opening of its specialty CGMP pharmaceutical outsourcing facility in Albany, NY for admixing, compounding, drug shortages and clinical studies and trials. The company meets and/or exceeds the FDA standards for safety and quality, using 21 CFR Part 210 and 21 CFR Part 211. The 10,000 square foot outsourcing facility was designed to provide the highest levels of quality assurance and quality control. The...

2014-10-20 08:31:44

- Taiho Oncology Initiates Rolling NDA Submission for TAS-102 - PRINCETON, N.J., Oct. 20, 2014 /PRNewswire/ -- Taiho Oncology, Inc., a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation for TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride), an oral combination anticancer drug under investigation for the treatment of refractory metastatic colorectal cancer (mCRC), and...

2014-10-20 08:31:41

First Patient Enrolled in PLATINUM Diversity Trial Evaluating Performance in Women, Black Americans, Latinos/Hispanics, Native Americans and Alaska Natives with Coronary Artery Disease MARLBOROUGH, Mass., Oct. 20, 2014 /PRNewswire/ -- As part of its commitment to innovation and improving patient outcomes, Boston Scientific Corporation (NYSE: BSX) has initiated the PLATINUM Diversity trial to evaluate the clinical performance of the Promus PREMIER((TM)) Everolimus-Eluting Platinum...

2014-10-20 08:31:31

Scientific and Technology Visionaries Join Senior Team as PureTech Expands its Emphasis on Interdisciplinary Innovation BOSTON, Oct. 20, 2014 /PRNewswire/ -- PureTech, a science and technology development and commercialization company tackling big healthcare problems, announced today the closing of a $55 million growth stage investment round, with participation from Invesco Perpetual, a $120 Billion group of funds. The funding will be used to drive PureTech's existing pipeline...


Latest Health Medical Pharma Reference Libraries

Damara Sheep
2014-09-25 08:50:59

The Damara sheep is a breed of domestic sheep that originated Egypt and Eastern Asia and eventually moved to the areas that are now Angola and Namibia. The breed became isolated in Namibia and southern Angola, where it remained free from the influence of other breeds for many years. It was named after the regions where it is known to have originated, which was once known as Gross Damaraland. The Damara sheep is a fat-tailed breed that can be black, brown, white, or black and white pied in...

British Milksheep
2014-09-22 07:50:24

The Bristish milksheep, previously known as the Alderbred, is a breed of domestic sheep that was developed in the Northumberland region of England. Although the exact origin of the breed is unknown, it is known to have been derived from flocks of the Eastrip Prolific, Dorset Horn, and Bluefaced Leicester breeds. Selective breeding was used to enhance productivity using breeds like the East Friesian and Texel, but this breeding did not focus on a uniform appearance. Later, the British...

Belgian Landrace
2014-08-27 09:35:46

The Belgian landrace, also known as the Belgian lop-eared, Belgian improved landrace, or the improved Belgian, is a breed of domestic pig that can be found in northern areas of Belgium. It was developed when English pigs were imported into Belgium, after which time they were improved upon until 1930, when they were bred with German landrace pigs. The resulting breed was crossbred with Dutch landrace pigs in 1945 and later other breeds including those from Germany and Luxemburg. This breed...

British Friesian Cattle
2014-07-12 11:44:10

The British Friesian is a breed of cattle from the United Kingdom. The modern British Friesian dominated the dairy cattle population from the 1950s through the 1980s. Stock as well as semen were exported during this time throughout the world. The original Friesian breed was imported to ports of England and Scotland during the 1800s until it was stopped in 1892 when a threat of foot and mouth disease became a concern. By the end of 1912 there were 1,000 bulls and 6,000 cows registered in...

Blue Gray Cattle
2014-07-12 10:27:38

The Blue Grey is a breed of beef cattle that is popular in Scotland and north of England. It was developed by crossing a white bred shorthorn and Black Galloway cows. The color of the Blue Grey is roan blue. However, roan coloration is not a dominant color gene and the color does not always hold true. Only about half of the calves born to two true blue roan cattle will be blue roan, the rest will be either solid white or solid black. Blue roan is only consistent in the first generation of...

More Articles (396 articles) »
Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related